Allogene Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Allogene Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $38M | 16M | 2.33 |
| 2024-03-31 | $43M | 9.7M | 4.47 |
| 2023-09-30 | $28M | 8.9M | 3.17 |
| 2023-06-30 | $42M | 8.4M | 4.97 |
| 2023-03-31 | $45M | 9.1M | 4.94 |
| 2022-12-31 | $56M | 8.9M | 6.29 |
| 2022-06-30 | $91M | 8.0M | 11.40 |
| 2021-06-30 | $183M | 7.0M | 26.08 |
| 2021-03-31 | $221M | 6.3M | 35.32 |
| 2020-12-31 | $163M | 6.5M | 25.23 |
| 2020-09-30 | $238M | 6.3M | 37.70 |
| 2020-03-31 | $95M | 4.9M | 19.42 |
| 2019-12-31 | $131M | 5.0M | 25.97 |
| 2019-09-30 | $109M | 4.0M | 27.27 |
| 2019-06-30 | $96M | 3.6M | 26.86 |
| 2019-03-31 | $65M | 2.3M | 28.90 |
| 2018-12-31 | $56M | 2.1M | 26.94 |